- Home
- LDP vs QSI Comparison
LDP vs QSI Comparison
Compare LDP & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDP
- QSI
- Stock Information
- Founded
- LDP 2012
- QSI 2013
- Country
- LDP United States
- QSI United States
- Employees
- LDP N/A
- QSI N/A
- Industry
- LDP Finance Companies
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- LDP Finance
- QSI Health Care
- Exchange
- LDP Nasdaq
- QSI Nasdaq
- Market Cap
- LDP 599.3M
- QSI 288.2M
- IPO Year
- LDP N/A
- QSI N/A
- Fundamental
- Price
- LDP $20.86
- QSI $1.92
- Analyst Decision
- LDP
- QSI Buy
- Analyst Count
- LDP 0
- QSI 2
- Target Price
- LDP N/A
- QSI $3.25
- AVG Volume (30 Days)
- LDP 102.5K
- QSI 24.0M
- Earning Date
- LDP 01-01-0001
- QSI 02-27-2025
- Dividend Yield
- LDP 7.91%
- QSI N/A
- EPS Growth
- LDP N/A
- QSI N/A
- EPS
- LDP N/A
- QSI N/A
- Revenue
- LDP N/A
- QSI $2,266,000.00
- Revenue This Year
- LDP N/A
- QSI $193.90
- Revenue Next Year
- LDP N/A
- QSI $173.18
- P/E Ratio
- LDP N/A
- QSI N/A
- Revenue Growth
- LDP N/A
- QSI 232.26
- 52 Week Low
- LDP $16.16
- QSI $0.61
- 52 Week High
- LDP $20.30
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- LDP 58.96
- QSI 42.87
- Support Level
- LDP $20.11
- QSI $2.26
- Resistance Level
- LDP $20.96
- QSI $2.12
- Average True Range (ATR)
- LDP 0.21
- QSI 0.25
- MACD
- LDP 0.06
- QSI -0.11
- Stochastic Oscillator
- LDP 81.50
- QSI 7.53
About LDP Cohen & Steers Limited Duration Preferred and Income Fund Inc.
Cohen & Steers Ltd Duration Preferred & Income Fund, Inc. is a diversified, closed-end management investment company. Its primary investment objective is high current income and capital appreciation is its secondary investment objective. The Fund invests at least its managed assets in preferred and other income securities issued by U.S. and non-U.S. companies under normal market conditions.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.